1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ACUTAAS CHEMICALS LTD.
Acutaas Chemicals Ltd.
NSE: ACUTAAS | BSE: 543349

Acutaas Chemicals Live Share Price Today, Share Analysis and Chart

Expensive Star
BasketIn 2 Starfolio Baskets
aboutAcutaas Chemicals Limited (formerly Ami Organics Limited) is a specialty chemicals manufacturer focused on advanced pharmaceutical intermediates and niche specialty chemicals. The company serves global markets by providing high-performance solutions ... Read More
US FDA Inspections
Ask AI about Acutaas Chemicals
4003.6026.90(0.68%)

New 52W High in past week

1.2M
NSE+BSE Volume

High vol.+gain this week

NSE 30 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Loading...
- / 100
- / 100
67.7 / 100
Expensive StarThese stocks are bullish, strong in quality and technicals, but expensive in valuation. Investors need to be cautiousView SimilarEmbed DVM
Analyst Price Target
-

36

S

6

W

6

O

0

T

SWOT Analysis

Check Before You Buy

VIEW FULL CHECKLIST

High rank

18Positive5Negative

Pass in checklist78.3%

045
55
100

Check P/E Buy Sell Zone

Sell Zone

70.0 %    into P/E buy sell zone

% time spent below current P/E
020406080100
Strong upside potential
Gains already realized

Acutaas Chemicals Stock Price Analysis

Day Price Range

0.7% 1 Day return
4003.6 (LTP)
3,906.24,024
LowHigh

Week Price Range

27.6% 1 Week return
4003.6 (LTP)
3,136.24,032.2
LowHigh

Month Price Range

21.2% 1 Month return
4003.6 (LTP)
3,031.14,032.2
LowHigh

52 Week Price Range

135.0% 1 Year return
4003.6 (LTP)
1,5704,032.2
LowHigh
View full Price History/Seasonality

Acutaas Chemicals Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

Hit

Acutaas Chemicals's Revenue was higher than average estimate 3 times in past 3 years

EPS forecast

CURRENT EPS
43.4
AVG. ESTIMATE
62.3
LOW ESTIMATE
59
HIGH ESTIMATE
65
CURRENT EPS
AVG. ESTIMATE
Hit

EPS is expected to grow by 43.6% in FY27

Consensus Recommendation

9 ANALYST Recommendations
BUY

The consensus recommendation from 9 analysts for Acutaas Chemicals is BUY

Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get
Upgrade Now

Acutaas Chemicals Technical Analysis

Acutaas Chemicals EMA & SMA

Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
5 Day3781.1
10 Day3587.0
12 Day3539.7
20 Day3430.9
26 Day3390.3
50 Day3320.8
100 Day3193.3
200 Day2854.1

Acutaas Chemicals Delivery And Volume

Daily Avg. Delivery Volume %
30 Oct, 202648.6%
Week29.4%
Month34.5%

Acutaas Chemicals Active Candlesticks

Three Outside Uptrend Inside Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Acutaas Chemicals Resistance and Support

3977.93
Pivot
First Resistance4049.7
Second Resistance4095.7
Third Resistance4167.5
First Support3931.9
Second Support3860.1
Third Support3814.1
Day RSI72.8
Day MACD149.4
Day MFI93.7
Day MACD Signal Line52.6

Acutaas Chemicals Beta

1 Month1.5
1 Year0.9
3 Month1.2
3 Year1.1

Acutaas Chemicals Price Change Analysis

↑21.2%
Over 1 Month
LowHigh
3031.14032.2
↑23.8%
Over 3 Months
LowHigh
30254032.2
↑60.0%
Over 6 Months
LowHigh
24864032.2
↑135.0%
Over 1 Year
LowHigh
15704032.2
All Technicals →

Acutaas Chemicals Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Nareshkumar Ramjibhai PatelPromoter14,483,32717.7 %
Government Pension Fund GlobalFii2,543,8383.1 %
Dhwani Girishkumar ChovatiaPublic2,739,0323.4 %
Kotak Mahindra Trustee Co Ltd A/C Kotak Nifty Alpha 50 Index FundDii2,340,6222.9 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

All Shareholding details

Acutaas Chemicals Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
ISHARES CORE MSCI EMERGING MARKETS ETFBulkPurchase24 Nov 20251852.12530,290NSE
CHETANKUMAR CHHAGANLAL VAGHASIABlockSell19 May 202511151,348,921NSE
NARESHKUMAR RAMJIBHAI PATELBlockSell19 May 202511151,348,921NSE
KOTAK MAHINDRA MUTUAL FUND.BlockPurchase19 May 202511151,348,921NSE
KOTAK MAHINDRA MUTUAL FUNDBlockPurchase19 May 202511151,348,921NSE
CHETANKUMAR CHHAGANLAL VAGHASIABulkSell19 May 202511151,348,921NSE
NARESHKUMAR RAMJIBHAI PATELBulkSell19 May 202511151,348,921NSE
KOTAK MAHINDRA MUTUAL FUND.BulkPurchase19 May 202511151,348,921NSE
KOTAK MAHINDRA MUTUAL FUNDBulkPurchase19 May 202511151,348,921NSE
GRAVITON RESEARCH CAPITAL LLPBulkSell02 May 20251188.04473,667NSE
All deals
All insider trades

Acutaas Chemicals Corporate Actions

Acutaas Chemicals Dividend history and yield

Acutaas Chemicals dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Acutaas Chemicals dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
117 Sep 2026
2.5FINAL17 Sep 2026Equity Share
218 Sep 2025
1.5FINAL18 Sep 2025Equity Share
313 Sep 2024
3FINAL13 Sep 2024Equity Share
418 Sep 2023
3FINAL18 Sep 2023Equity Share
529 Jul 2022
3FINAL01 Aug 2022Equity Share

Acutaas Chemicals Board Meetings

Acutaas Chemicals past and upcoming board meetings.

#Ex-Date
PurposeNotes
127 Oct 2026
Quarterly Results-
224 Jul 2026
Quarterly Results-
330 Apr 2026
Audited Results & Final Dividend-
428 Jan 2026
Quarterly Results-
517 Oct 2025
Quarterly Results-

Acutaas Chemicals Stock Split

Acutaas Chemicals stock split details, including announcement, record, and ex-split dates, along with the split ratios

#Ex-Date
Old FVNew FVRecord Date
125 Apr 2025
10525 Apr 2025
All Corporate Actions

Acutaas Chemicals Research Reports

Acutaas Chemicals research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
128 Jul 2026Deven Choksey
Target
35673297.7Accumulate8.17%21.41%pdf
226 Jul 2026IDBI Capital
Target
40013367.8Buy18.8%18.88%pdf
303 May 2026IDBI Capital
Target
30012676.4Buy12.13%49.59%pdf
403 May 2026Deven Choksey
Target
29412676.4Accumulate9.89%49.59%pdf
528 Jan 2026Geojit BNP Paribas23501934.1Buy21.5%107%pdf
All Reports of Acutaas

Acutaas Chemicals Corporate Filings

Acutaas Chemicals BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
28 Oct 2026
Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication of the Unaudited Financial Results for the second quarter ended September 30, 2026 as attached.
PDF
27 Oct 2026
Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Recording to earnings call held on October 27, 2026 is attached.
PDF
27 Oct 2026
Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on financial results for the second quarter and half year ended as on September 30, 2026 is enclosed.
PDF
27 Oct 2026
Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release discussing the financial results for the second quarter and half year ended as on September 30, 2026 is attached.
PDF
27 Oct 2026
Q2FY27 Quarterly Result Announced for Acutaas Chemicals Ltd.
Pharmaceuticals company Acutaas Chemicals announced Q2FY27 results Standalone Financial Highlights: Revenue from Operations for Q2FY27 was Rs 43,304.85 lakh, showing a QoQ increase of 34.32% from Rs 32,240.92 lakh in Q1FY27 and a YoY increase of 41.89% from Rs 30,519.34 lakh in Q2FY26. For H1FY27, Revenue from Operations arrived at Rs 75,545.77 lakh, recording a YoY growth of 47.79% over Rs 51,116. 43 lakh in H1FY26. Total Income reached Rs 44,109.41 lakh during Q2FY27, gaining 33.07% QoQ against Rs 33,147.61 lakh in Q1FY27 and expanding 40.40% YoY from Rs 31,416.29 lakh in Q2FY26. For H1FY27, Total Income accumulated to Rs 76,797.93 lakh, showcasing a YoY expansion of 43.24% compared to Rs 53,615.39 lakh in H1FY26. Profit Before Tax (PBT) stood at Rs 18,108.08 lakh in Q2FY27, indicating a QoQ increase of 74.09% over Rs 10,401.50 lakh in Q1FY27 and a YoY increase of 86.14% from Rs 9,728.14 lakh in Q2FY26. For H1FY27, PBT was Rs 28,509.58 lakh, climbing by 82.51% YoY against Rs 15,620.84 lakh in H1FY26. Profit After Tax (PAT) for Q2FY27 stood at Rs 13,573.66 lakh, representing a QoQ growth of 78.85% from Rs 7,589.57 lakh in Q1FY27 and a YoY growth of 86.22% compared to Rs 7,289.16 lakh in Q2FY26. For H1FY27, PAT stood at Rs 21,163.23 lakh, marking an 80.05% YoY rise over Rs 11,753.78 lakh in H1FY26. Basic Earnings Per Share (EPS) recorded Rs 16.58 in Q2FY27, up from Rs 9.27 QoQ in Q1FY27 and increasing by 86.29% YoY from Rs 8.90 in Q2FY26. For H1FY27, Basic EPS was Rs 25.85, rising 80.01% YoY from Rs 14.36 in H1FY26. Consolidated Financial Highlights: Revenue from Operations for Q2FY27 reached Rs 43,691.64 lakh, generating a QoQ shift of 32.53% over Rs 32,967.48 lakh in Q1FY27 and a YoY progress of 42.69% over Rs 30,619.58 lakh in Q2FY26. For H1FY27, Revenue from Operations hit Rs 76,659.12 lakh, turning in a YoY increase of 49.31% versus Rs 51,343.30 lakh in H1FY26. Total Income stood at Rs 44,201.49 lakh during Q2FY27, demonstrating a QoQ push of 33.35% relative to Rs 33,147.61 lakh in Q1FY27 and a YoY build of 39.86% over Rs 31,603.31 lakh in Q2FY26. For H1FY27, Total Income accumulated to Rs 77,349.10 lakh, translating to a YoY increase of 43.45% above Rs 53,920.80 lakh in H1FY26. Profit Before Tax (PBT) came in at Rs 16,736.18 lakh in Q2FY27, ascending 61.06% QoQ up from Rs 10,391.01 lakh in Q1FY27 and expanding 74.01% YoY against Rs 9,617.98 lakh in Q2FY26. For H1FY27, PBT was Rs 27,127.19 lakh, moving up by 75.86% YoY compared to Rs 15,425.55 lakh in H1FY26. Profit After Tax (PAT) for Q2FY27 arrived at Rs 12,314.25 lakh, establishing a QoQ lift of 64.21% against Rs 7,499.27 lakh in Q1FY27 and a YoY lift of 71.37% against Rs 7,185.59 lakh in Q2FY26. For H1FY27, PAT landed at Rs 19,813.52 lakh, delivering a YoY advance of 71.00% from Rs 11,586.64 lakh in H1FY26. Basic Earnings Per Share (EPS) stood at Rs 15.29 in Q2FY27, climbing from Rs 9.07 QoQ in Q1FY27 and increasing by 73.36% YoY from Rs 8.82 in Q2FY26. For H1FY27, Basic EPS stood at Rs 24.36, proving a YoY climb of 71.19% out of Rs 14.23 in H1FY26. Result PDF
PDF
VIEW ALL

Acutaas Chemicals DocumentsAsk MarketMind AI

Acutaas Chemicals Earnings Call

Acutaas Chemicals earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
27 Oct 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeLink
28 Jul 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
24 Jul 2026Acutaas Chemicals Ltd - 543349 - Earnings Call Recording Pursuant To SEBI (LODR) Regulations, 2015Link
06 May 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
03 Feb 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Earnings Call TranscriptLink
view all

Acutaas Chemicals Annual Reports

Acutaas Chemicals financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026Link
2025Annual Report Mar-2025Link
2025Annual Report Mar-2025Link
2024Annual Report Mar-2024Link
2023Annual Report Mar-2023Link

Acutaas Chemicals Credit Ratings

Acutaas Chemicals credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
08 Dec 2025care ratingsACUTAAS CHEMICALS LIMITEDLink
25 Dec 2024care ratingsAmi Organics LimitedLink
22 Nov 2023care ratingsAmi Organics LimitedLink

Acutaas Chemicals Investor Presentations

Acutaas Chemicals investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
27 Oct 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
24 Jul 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
16 May 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
30 Apr 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor PresentationLink
28 Jan 2026Acutaas Chemicals Ltd - 543349 - Announcement under Regulation 30 (LODR)-Investor PresentationLink

Acutaas Chemicals - Company Profile

Acutaas Chemicals Management Structure

Acutaas Chemicals management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Abhishek Haribhai PatelPresident,Head(Strategy,Growth)103Mar 26
Mr. Patel Vinaykumar HirabhaiDeputy General Manager,Head(Quality Assurance)-Mar 26
Mr. Gaurav Pravin BhandariAssistant General Manager-Mar 26
Mr. Desai Naineshkumar RAssistant General Manager-Mar 26
Mr. Anurag ShuklaGeneral Manager,Head(Unit II)-Mar 26
Mr. Snehal ShahSenior General Manager,Head(Project.,Instrumentation)-Mar 26
Mr. Chetansinh Amaratsinh ParmarChief Information Security Officer,Head(IT,Compliance)-Mar 26
Mr. Uday Nagesh DesaiGeneral Manager,Head(Unit III)-Mar 26
Mr. Sarvesh KumarDeputy General Manager,Head(Pilot Plant)-Mar 26
Mr. Akshay Kumar TripathiDeputy General Manager,Head(Unit I)-Mar 26
Ekta Kumari SrivastavaCompany Secretary,Compliance Officer,Head(Secretarial,Legal.)-Mar 26
Mr. Satish Shivanand RevankarGeneral Manager,Head(IT,Information Security)-Mar 26
Mr. Manharbhai Lallubhai PatelAssistant General Manager,Head(Supply Chain.,Logistics)-Mar 26
Mr. Jayesh KhatriDeputy General Manager,Head(Quality Control)-Mar 26
Mr. Sanjaykumar Lakhabhai VasoyaAssistant Vice President,Head(Research & Development)-Mar 26
Mr. Nainesh R. DesaiAssistant General Manager,Head(Purchase,Procurement)-Mar 26
Mr. Gaurav P. BhandariAssistant General Manager,Head(Marketing,Business Development)-Mar 26
Mr. Patel Hemantkumar MahendrabhaiSenior General Manager(Human Resources),Head(Labour & Welfare)-Mar 26
Dr. Ajit Kumar ChoubeyPresident - Technical,Head(Research & Development)-Mar 26
Mr. Bhavin Navinchandra ShahChief Financial Officer,Head(Accounts, Taxation & Finance)-Mar 26

Acutaas Chemicals Board of Directors

Acutaas Chemicals Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Nareshbhai Ramjibhai PatelExecutive Chairman & M.D.492Mar 25
Chetankumar Chhaganlal VaghasiaE D & Wholetime Director485.2Mar 25
Ram Mohan Rao LocandeE D & Wholetime Director156.4Mar 25
Virendra Nath MishraE D & Wholetime Director133.8Mar 25
Girikrishna ManiarIndependent Non Exe. Director20Mar 25
Hetal GandhiIndependent Non Exe. Director20Mar 25
Richa M. GoyalIndependent Non Exe. Director10Mar 25
Anita BandyopadhyayIndependent Non Exe. Director10Mar 25
Ekta Kumari SrivastavaCS / Compliance Officer / Legal Head-Mar 25
Website: www.amiorganics.com

About the company - Business Profile

Acutaas Chemicals Limited (formerly Ami Organics Limited) is a specialty chemicals manufacturer focused on advanced pharmaceutical intermediates and niche specialty chemicals. The company serves global markets by providing high-performance solutions for the pharmaceutical, semiconductor, and energy storage industries. With a strong research foundation, it maintains a significant presence in over 55 countries, positioning itself as a critical supplier in the global specialty chemicals value chain.

Key Points

  • Key Facts:
    • Founded: 2007 (as Ami Organics).
    • Headquarters: Surat, Gujarat.
    • Stock Listing: Listed on NSE (Ticker: ACUTAAS) and BSE (Scrip Code: 543349).
    • Market Capitalization: Approximately ₹13,958 crore (as of December 2025).
  • Operations and Resources:
    • The company operates four manufacturing facilities located in Sachin, Ankleshwar, and Jhagadia (Gujarat) and Greater Noida (Uttar Pradesh).
    • Its R&D center is approved by the Department of Scientific and Industrial Research (DSIR).
    • The Sachin facility recently received a Good Manufacturing Practices (GMP) compliance report from PMDA, Japan.
  • Ownership and Governance:
    • Promoter Holding: 32.7% (as of December 31, 2025).
    • Institutional Holding: Foreign Institutional Investors (FII) hold 16.7%, and Mutual Funds hold 15.1%.
    • The company is led by Mr. Naresh Patel, Executive Chairman and Managing Director.
  • Market Significance:
    • Acutaas Chemicals provides electrolyte additives for lithium-ion batteries and photoresist chemicals for the semiconductor industry.
    • It exports approximately 74% of its total revenue, serving a diverse customer base of approximately 600 clients globally across regions like Europe, Asia, and the Americas.
  • Financial Performance (FY2024-25):
    • Total Revenue: ₹1,023.8 crore.
    • Revenue from Operations: ₹1,006.9 crore.
    • EBITDA: ₹232.1 crore (EBITDA Margin: 23.0%).
    • Profit After Tax (PAT): ₹160.4 crore.
  • Revenue Breakdown:
    • By Segment: The business is primarily divided into Pharmaceutical Intermediates and Specialty Chemicals.
    • By Geography: Exports accounted for 74% of total revenue in FY2025.
  • Technology and Innovation:
    • The company holds 10 process patents in advanced pharmaceutical intermediates.
    • Its R&D focus is on developing complex chemistries for high-growth sectors like electronics and energy storage.
  • Strategic Initiatives:
    • The company recently raised ₹500 crore through a Qualified Institutional Placement (QIP) and preferential allotment to deleverage its balance sheet.
    • Sustainability efforts are integrated into operations, with 26,133 kl of water recycled and 62% of total waste recycled in FY2025.

References

  1. Annual Report May 2025
  2. Investor Presentation Jan 2026
  3. Investor Presentation Oct 2025
  4. Result Jan 2026

Acutaas Chemicals FAQ

Acutaas Chemicals today is trading in the green, up by 0.68% at ₹4,003.6.
Acutaas Chemicals is currently trading up 0.68% on an intraday basis. In the past week the stock rose 27.6%. Stock has been up 23.8% in the past quarter and rose 135.02% in the past year. You can view this in the share price history/seasonality section.
Acutaas Chemicals is listed on NSE with the ticker ACUTAAS and on BSE as 543349. It's currently trading on NSE at a share price of ₹4,003.6 and on BSE with a share price of ₹4,010.
The market cap of Acutaas Chemicals is ₹32,777.91 Cr. as of Oct 30, 2026.
Acutaas Chemicals announced a FINAL dividend of 50% which equals ₹2.5 in Sep 17, 2026.The last three ex-dates for Acutaas Chemicals were Sep 18, 2025, Sep 13, 2024 and Sep 18, 2023. To view the full dividend history of Acutaas Chemicals click here.
Acutaas Chemicals has never issued bonus shares, but it has issued 1 stock split since its BSE/NSE listing. The latest announcement for Acutaas Chemicals stock split was on Apr 25, 2025 at a ratio of 10:5.
Acutaas Chemicals reported ₹442.01 Cr. in revenue, ₹125.17 Cr. in net profit, and ₹181.06 Cr. in EBITD as of Oct 27, 2026 for Q2 FY26-27.
According to the predictions of 9 analysts, the share price prediction for Acutaas Chemicals is ₹3,551.67 with a downside of 11%.
The PE ratio of Acutaas Chemicals is 74.64 as of Oct 30, 2026.
The PB ratio of Acutaas Chemicals is 18.96 as of Oct 30, 2026.
You can view the latest analyst reports on the Acutaas Chemicals reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.
Ask AI
×